Incremental utility of circulating biomarkers for cardiovascular risk prediction beyond the updated SCORE2 model

29 August 2022 (10:15 - 11:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Jonas Lehmacher

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

6 More presentations in this session

Presentation thumbnail

Cardiovascular disease-wide association study to investigate shared genetics with peak oxygen uptake

Miss A. Nordeidet (Trondheim, NO)

Abstract Slides

Presentation thumbnail

Sex and gender influence on cardiovascular health in sub-saharan Africa: findings from Ghana, Gambia, Mali, Guinea, and Botswana

Professor C. Norris (Edmonton, CA)

Abstract Slides

Presentation thumbnail

Mortality and predictors of death in women and men with congestive heart failure with preserved, mildly reduced, and reducedejection fraction

Doctor A. Mansur (Sao Paulo, BR)

Abstract Slides

Presentation thumbnail

Impact of metabolic syndrome and its components on the progression of coronary artery calcification in statin-naive young adults: results from the KOICA registry

Doctor H. Ahn (Seoul, KR)

Abstract Slides

Presentation thumbnail

Myocardial function and myocardial work in young adults born very preterm or with extremely low birthweight - a regional cohort study

Doctor B. Engan (Bergen, NO)

Abstract Slides

Access the full session

Session thumbnail

Cardiovascular risk assessment 2

The Event

Event poster

ESC Congress 2022

29 August 2022 10:15 CET

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Webinar

Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources